{"pmid":32241814,"title":"Emergency departments and the COVID-19 pandemic: making the most of limited resources.","text":["Emergency departments and the COVID-19 pandemic: making the most of limited resources.","Emerg Med J","Mitchell, Rob","Banks, Colin","32241814"],"journal":"Emerg Med J","authors":["Mitchell, Rob","Banks, Colin"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32241814","week":"202014|Mar 30 - Apr 05","doi":"10.1136/emermed-2020-209660","keywords":["disaster planning and response","infectious diseases"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663079112912142336,"score":7.6048946,"similar":[{"pmid":32098302,"title":"Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development.","text":["Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development.","Novel Coronavirus (2019-nCoV) is an emerging pathogen that was first identified in Wuhan, China in late December 2019. This virus is responsible for the ongoing outbreak that causes severe respiratory illness and pneumonia-like infection in humans. Due to the increasing number of cases in China and outside China, the WHO declared coronavirus as a global health emergency. Nearly 35,000 cases were reported and at least 24 other countries or territories have reported coronavirus cases as early on as February. Inter-human transmission was reported in a few countries, including the United States. Neither an effective anti-viral nor a vaccine is currently available to treat this infection. As the virus is a newly emerging pathogen, many questions remain unanswered regarding the virus's reservoirs, pathogenesis, transmissibility, and much more is unknown. The collaborative efforts of researchers are needed to fill the knowledge gaps about this new virus, to develop the proper diagnostic tools, and effective treatment to combat this infection. Recent advancements in plant biotechnology proved that plants have the ability to produce vaccines or biopharmaceuticals rapidly in a short time. In this review, the outbreak of 2019-nCoV in China, the need for rapid vaccine development, and the potential of a plant system for biopharmaceutical development are discussed.","Pathogens","Shanmugaraj, Balamurugan","Malla, Ashwini","Phoolcharoen, Waranyoo","32098302"],"abstract":["Novel Coronavirus (2019-nCoV) is an emerging pathogen that was first identified in Wuhan, China in late December 2019. This virus is responsible for the ongoing outbreak that causes severe respiratory illness and pneumonia-like infection in humans. Due to the increasing number of cases in China and outside China, the WHO declared coronavirus as a global health emergency. Nearly 35,000 cases were reported and at least 24 other countries or territories have reported coronavirus cases as early on as February. Inter-human transmission was reported in a few countries, including the United States. Neither an effective anti-viral nor a vaccine is currently available to treat this infection. As the virus is a newly emerging pathogen, many questions remain unanswered regarding the virus's reservoirs, pathogenesis, transmissibility, and much more is unknown. The collaborative efforts of researchers are needed to fill the knowledge gaps about this new virus, to develop the proper diagnostic tools, and effective treatment to combat this infection. Recent advancements in plant biotechnology proved that plants have the ability to produce vaccines or biopharmaceuticals rapidly in a short time. In this review, the outbreak of 2019-nCoV in China, the need for rapid vaccine development, and the potential of a plant system for biopharmaceutical development are discussed."],"journal":"Pathogens","authors":["Shanmugaraj, Balamurugan","Malla, Ashwini","Phoolcharoen, Waranyoo"],"date":"2020-02-27T11:00:00Z","year":2020,"_id":"32098302","week":"20209|Feb 24 - Mar 01","doi":"10.3390/pathogens9020148","keywords":["biopharmaceuticals","coronavirus","emerging threat","infectious diseases","plant system","transient expression","viruses","zoonoses"],"source":"PubMed","locations":["China","United States","Wuhan"],"countries":["China","United States"],"countries_codes":["CHN|China","USA|United States"],"topics":["Treatment"],"weight":1,"_version_":1662334544287629312,"score":44.18335},{"pmid":32224710,"title":"How emergency departments prepare for virus disease outbreaks like COVID-19.","text":["How emergency departments prepare for virus disease outbreaks like COVID-19.","Eur J Emerg Med","Mockel, Martin","Bachmann, Ulrike","Behringer, Wilhelm","Pfafflin, Frieder","Stegemann, Miriam Songa","32224710"],"journal":"Eur J Emerg Med","authors":["Mockel, Martin","Bachmann, Ulrike","Behringer, Wilhelm","Pfafflin, Frieder","Stegemann, Miriam Songa"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32224710","week":"202014|Mar 30 - Apr 05","doi":"10.1097/MEJ.0000000000000703","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1662819280317579264,"score":42.819256},{"pmid":32238613,"title":"Novel Coronavirus 2019 (2019-nCoV) Infection: Part II - Respiratory Support in the Pediatric Intensive Care Unit in Resource-limited Settings.","text":["Novel Coronavirus 2019 (2019-nCoV) Infection: Part II - Respiratory Support in the Pediatric Intensive Care Unit in Resource-limited Settings.","The 2019-novel coronavirus predominantly affects the respiratory system with manifestations ranging from upper respiratory symptoms to full blown acute respiratory distress syndrome (ARDS). It is important to recognize the risk factors, categorize severity and provide early treatment. Use of high flow devices and non-invasive ventilation has been discouraged due to high chances of aerosol generation. Early intubation and mechanical ventilation are essential to prevent complications and worsening, especially in resource-limited settings with very few centers having expertise to manage critical cases. Hydrophobic viral filter in the ventilator circuit minimizes chances of transmission of virus. Strategies to manage ARDS in COVID-19 include low tidal volume ventilation with liberal sedation-analgesia. At the same time, prevention of transmission of the virus to healthcare workers is extremely important in the intensive care setting dealing with severe cases and requiring procedures generating aerosol. We, herein, provide guidance on non-invasive respiratory support, intubation and management of ARDS in a child with COVID-19.","Indian Pediatr","Sundaram, Manu","Ravikumar, Namita","Bansal, Arun","Nallasamy, Karthi","Basavaraja, G V","Lodha, Rakesh","Gupta, Dhiren","Odena, Marti Pons","Ashwath, R N Ram","Jayashree, Muralidharan","32238613"],"abstract":["The 2019-novel coronavirus predominantly affects the respiratory system with manifestations ranging from upper respiratory symptoms to full blown acute respiratory distress syndrome (ARDS). It is important to recognize the risk factors, categorize severity and provide early treatment. Use of high flow devices and non-invasive ventilation has been discouraged due to high chances of aerosol generation. Early intubation and mechanical ventilation are essential to prevent complications and worsening, especially in resource-limited settings with very few centers having expertise to manage critical cases. Hydrophobic viral filter in the ventilator circuit minimizes chances of transmission of virus. Strategies to manage ARDS in COVID-19 include low tidal volume ventilation with liberal sedation-analgesia. At the same time, prevention of transmission of the virus to healthcare workers is extremely important in the intensive care setting dealing with severe cases and requiring procedures generating aerosol. We, herein, provide guidance on non-invasive respiratory support, intubation and management of ARDS in a child with COVID-19."],"journal":"Indian Pediatr","authors":["Sundaram, Manu","Ravikumar, Namita","Bansal, Arun","Nallasamy, Karthi","Basavaraja, G V","Lodha, Rakesh","Gupta, Dhiren","Odena, Marti Pons","Ashwath, R N Ram","Jayashree, Muralidharan"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238613","week":"202014|Mar 30 - Apr 05","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1662996001737146368,"score":42.347897},{"pmid":32238612,"title":"Novel Coronavirus 2019 (2019-nCoV) Infection: Part I - Preparedness and Management in the Pediatric Intensive Care Unit in Resource-limited Settings.","text":["Novel Coronavirus 2019 (2019-nCoV) Infection: Part I - Preparedness and Management in the Pediatric Intensive Care Unit in Resource-limited Settings.","First reported in China, the 2019 novel coronavirus has been spreading across globe. Till 26 March, 2020, 416,686 cases have been diagnosed and 18,589 have died the world over. The coronavirus disease mainly starts with a respiratory illness and about 5%-16% require intensive care management for acute respiratory distress syndrome (ARDS) and multi-organ dysfunction. Children account for about 1%-2% of the total cases, and 6% of these fall under severe or critical category requiring pediatric intensive care unit (PICU) care. Diagnosis involves a combination of clinical and epidemiological features with laboratory confirmation. Preparedness strategies for managing this pandemic are the need of the hour, and involve setting up cohort ICUs with isolation rooms. Re-allocation of resources in managing this crisis involves careful planning, halting elective surgeries and training of healthcare workers. Strict adherence to infection control like personal protective equipment and disinfection is the key to contain the disease transmission. Although many therapies have been tried in various reigns, there is a lack of strong evidence to recommend anti-virals or immunomodulatory drugs.","Indian Pediatr","Ravikumar, Namita","Nallasamy, Karthi","Bansal, Arun","Angurana, Suresh Kumar","Basavaraja, G V","Sundaram, Manu","Lodha, Rakesh","Gupta, Dhiren","Jayashree, Muralidharan","32238612"],"abstract":["First reported in China, the 2019 novel coronavirus has been spreading across globe. Till 26 March, 2020, 416,686 cases have been diagnosed and 18,589 have died the world over. The coronavirus disease mainly starts with a respiratory illness and about 5%-16% require intensive care management for acute respiratory distress syndrome (ARDS) and multi-organ dysfunction. Children account for about 1%-2% of the total cases, and 6% of these fall under severe or critical category requiring pediatric intensive care unit (PICU) care. Diagnosis involves a combination of clinical and epidemiological features with laboratory confirmation. Preparedness strategies for managing this pandemic are the need of the hour, and involve setting up cohort ICUs with isolation rooms. Re-allocation of resources in managing this crisis involves careful planning, halting elective surgeries and training of healthcare workers. Strict adherence to infection control like personal protective equipment and disinfection is the key to contain the disease transmission. Although many therapies have been tried in various reigns, there is a lack of strong evidence to recommend anti-virals or immunomodulatory drugs."],"journal":"Indian Pediatr","authors":["Ravikumar, Namita","Nallasamy, Karthi","Bansal, Arun","Angurana, Suresh Kumar","Basavaraja, G V","Sundaram, Manu","Lodha, Rakesh","Gupta, Dhiren","Jayashree, Muralidharan"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32238612","week":"202014|Mar 30 - Apr 05","source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1662996001805303808,"score":42.347897},{"pmid":32212058,"title":"Protecting healthcare personnel from 2019-nCoV infection risks: lessons and suggestions.","text":["Protecting healthcare personnel from 2019-nCoV infection risks: lessons and suggestions.","The outbreak of a novel Coronavirus disease (COVID-19, caused by the 2019-nCoV infection) in December 2019 is one of the most severe public health emergencies since the founding of People's Republic of China in 1949. Healthcare personnel (HCP) nationwide are facing heavy workloads and high risk of infection, especially those who care for patients at the epicenter of the outbreak, Hubei Province. Sadly, as of February 20, 2020, over two thousand COVID-19 cases are confirmed among HCP from 476 hospitals nationwide, with nearly 90% of them from Hubei Province. Based on literature search and interviews with some HCP working at Wuhan, capital city of Hubei, we have summarized some of the effective measures taken to reduce infection among HCP, and also made suggestions for improving occupational safety during an infectious disease outbreak. The experience and lessons learned should be a valuable asset for international health community to contain the ongoing COVID-19 epidemic around the world.","Front Med","Zhang, Zhiruo","Liu, Shelan","Xiang, Mi","Li, Shijian","Zhao, Dahai","Huang, Chaolin","Chen, Saijuan","32212058"],"abstract":["The outbreak of a novel Coronavirus disease (COVID-19, caused by the 2019-nCoV infection) in December 2019 is one of the most severe public health emergencies since the founding of People's Republic of China in 1949. Healthcare personnel (HCP) nationwide are facing heavy workloads and high risk of infection, especially those who care for patients at the epicenter of the outbreak, Hubei Province. Sadly, as of February 20, 2020, over two thousand COVID-19 cases are confirmed among HCP from 476 hospitals nationwide, with nearly 90% of them from Hubei Province. Based on literature search and interviews with some HCP working at Wuhan, capital city of Hubei, we have summarized some of the effective measures taken to reduce infection among HCP, and also made suggestions for improving occupational safety during an infectious disease outbreak. The experience and lessons learned should be a valuable asset for international health community to contain the ongoing COVID-19 epidemic around the world."],"journal":"Front Med","authors":["Zhang, Zhiruo","Liu, Shelan","Xiang, Mi","Li, Shijian","Zhao, Dahai","Huang, Chaolin","Chen, Saijuan"],"date":"2020-03-27T11:00:00Z","year":2020,"_id":"32212058","week":"202013|Mar 23 - Mar 29","doi":"10.1007/s11684-020-0765-x","keywords":["COVID-19","healthcare personnel","infectious diseases"],"source":"PubMed","locations":["Hubei","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1662444220119515136,"score":42.144993}]}